BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
72
Comprehensive analysis of kinase inhibitor selectivity.EBI
Ambit Biosciences
1
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.EBI
Eli Lilly
31
Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.EBI
Universite de Tours
28
Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial EBI
University of North Carolina at Chapel Hill
35
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against EBI
Glaxosmithkline
8
Plasmodial Kinase Inhibitors: License to Cure?EBI
TBA
36
Compounds as diacylglycerol acyltransferase inhibitorsBDB
Glaxosmithkline
13
In vivo and in vitro effect of androstene derivatives as 5a-reductase type 1 enzyme inhibitors.BDB
National University of Mexico City
2
D3 dopamine receptor agonists to treat dyskinesia in parkinson's diseaseBDB
Drexel University